Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Latest
Popular

Trial results at ASH 2013

Prof Ian Flinn - Sarah Cannon Cancer Center, Nashville, Tennessee, USA
Trial results at ASH 2013 ( Prof Ian Flinn - Sarah Cannon Cancer Center, Nashville, Tennessee, USA )
1 Jan 2014

Rituximab maintenance therapy and CLL treatment considerations going forward

Prof Ulrich Jäger - Medical University of Vienna, Austria
Rituximab maintenance therapy and CLL treatment considerations going forward ( Prof Ulrich Jäger - Medical University of Vienna, Austria )
1 Jan 2014

Translational studies of CDK and PARP inhibitors

Dr Geoffry Shapiro - Dana Farber Cancer Institute, Boston, USA
Translational studies of CDK and PARP inhibitors ( Dr Geoffry Shapiro - Dana Farber Cancer Institute, Boston, USA )
19 Dec 2013

HER2 positive breast cancer treatment, past and future

Dr Edith Perez - Mayo Clinic, Rochester, USA
HER2 positive breast cancer treatment, past and future ( Dr Edith Perez - Mayo Clinic, Rochester, USA )
19 Dec 2013

Moving breast cancer stem cell therapies to the clinic

Dr Max Wicha - University of Michigan, Ann Arbor, USA
Moving breast cancer stem cell therapies to the clinic ( Dr Max Wicha - University of Michigan, Ann Arbor, USA )
19 Dec 2013

PIK3CA mutation predicts resistance to anti-HER2 treatment and chemotherapy

Dr Sibylle Loibl - German Breast Cancer Group
PIK3CA mutation predicts resistance to anti-HER2 treatment and chemotherapy ( Dr Sibylle Loibl - German Breast Cancer Group )
19 Dec 2013

Where to next for the elderly with acute myeloid leukaemia?

Dr Uwe Platzbecker - University Hospital Dresden, Germany and Prof Gert Ossenkoppele - VU University Medical Center, Amsterdam, Netherlands
Where to next for the elderly with acute myeloid leukaemia? ( Dr Uwe Platzbecker - University Hospital Dresden, Germany and Prof Gert Ossenkoppele - VU University Medical Center, Amsterdam, Netherlands )
19 Dec 2013

Novel agent CC-292 for CLL using the B-cell receptor pathway

Dr Jennifer Brown - Dana-Farber Cancer Institute, Boston, USA
Novel agent CC-292 for CLL using the B-cell receptor pathway ( Dr Jennifer Brown - Dana-Farber Cancer Institute, Boston, USA )
18 Dec 2013

Encouraging early results with GS-9973 for CLL and NHL

Dr Jeff Sharman- US Oncology, Eugene, Oregon
Encouraging early results with GS-9973 for CLL and NHL ( Dr Jeff Sharman- US Oncology, Eugene, Oregon )
18 Dec 2013

PI3K-delta inhibitor idelalisib success in CLL

Dr Jennifer Brown - Dana-Farber Cancer Institute, Boston, USA
PI3K-delta inhibitor idelalisib success in CLL ( Dr Jennifer Brown - Dana-Farber Cancer Institute, Boston, USA )
18 Dec 2013

Benefit of lenalidomide and low-dose dexamethasone over standard therapy for multiple myeloma

Dr Thierry Facon - Centre Hospitalier Régional Universitaire de Lille, Lille, France
Benefit of lenalidomide and low-dose dexamethasone over standard therapy for multiple myeloma ( Dr Thierry Facon - Centre Hospitalier Régional Universitaire de Lille, Lille, France )
18 Dec 2013

T cell immunotherapy for leukaemia in preclinical setting

Dr Michael Kalos - University of Pennsylvania, Philadelphia, USA
T cell immunotherapy for leukaemia in preclinical setting ( Dr Michael Kalos - University of Pennsylvania, Philadelphia, USA )
17 Dec 2013

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation